Now there’s one more alternative medication for GERD, soon to be released from Takeda as Prevacid nears patent expiration. As the article states, choices for treatment of GERD certainly are not limited and this is really nothing new as many drugs have been re-created with the same type of time released actions. BD
Deerfield-based Takeda Pharmaceuticals North America Inc. said Friday evening its heartburn drug Kapidex was approved by the Food and Drug Administration, entering the crowded field of prescription proton pump inhibitors.
The FDA approved Kapidex "delayed release capsules" for the treatment of gastroesophageal reflux disease, commonly known as GERD. Kapidex is in the same proton pump inhibitor class of drugs as Takeda's Prevacid, which loses patent protection later this year and faces competition from cheaper generics.
FDA approves Takeda's latest heartburn drug Kapidex -- chicagotribune.com
![EZClaim[4]](http://lh4.ggpht.com/_v3zjJigoAPE/TG1-9etl5ZI/AAAAAAAAgqg/CRMlet5Pi5k/EZClaim44.png?imgmax=800 "EZClaim[4]")
Math–This Could be a Subject for Michael Moore to Explore and Document In a Movie
Screenings Too–Killer Algorithms Part 12–Medical Billing Codes Style
Assessing Consumer Credit Scores–Attack of the Killer Algorithms Chapter 21 With Flawed Data
Duping” Society Combined With A World of Rogue Algorithms & Flawed Data Continues In Markets As Seen With Knight Capital This Week-Attack of the Killer Algorithms Chapter 36
Study Fraud With EHR Technologies, Namely Medical Records/Billing Software Used by Hospitals– HHS And SEC Continue Getting Their Non-Algorithmic Fannies Kicked–Attack of the Killer Algorithms Chapter 46
SilverScript Senior Drug Program Sanctioned by Medicare Until the Payment And Billing Algorithms are Cleaned Up-Killer Algorithms Chapter 53
